Current landscape and future directions of neoantigen vaccines: A new era of personalized cancer immunotherapy (IMAGE)
Caption
- Neoantigens are tumor-specific and highly immunogenic targets for personalized cancer immunotherapy.
- Artificial intelligence (AI) improves neoantigen prediction, yet challenges remain in accuracy.
- Diverse vaccine platforms show promise in clinical trials.
- Combination therapies are crucial for enhancing antitumor efficacy of neoantigen vaccines.
Credit
Wang X., Su S., Tan S., et al., (2026). Current landscape and future directions of neoantigen vaccines: A new era of personalized cancer immunotherapy. The Innovation 7(9), 101357.
Usage Restrictions
Credit must be given to the creator.
License
CC BY